Analyzing the results of 15 different studies involving over 300 subjects, researchers discovered a single dose of THC could induce psychiatric symptoms in people with no history of psychosis.
37% of Millenials and 25% of Gen Xers say they have used cannabinoids to help relieve pain.
Pure CBD products will not cause a positive drug test, but low-THC/high-CBD products may trigger a positive drug test for some users.
The effect cannabidiol has on Lennox-Gastaut syndrome may be explained by the drug-drug interaction between CBD and anti-seizure medication.
Ninety percent of medical marijuana products offered at dispensaries are far stronger than recommended for chronic pain relief.
A new study aims to determine if the cannabis compound CBD can help to alleviate adverse symptoms associated with ASD.
H2CBD, a synthetic version of the cannabis compound CBD, has been found to be effective in decreasing the number and severity of seizures in rats.
Researchers report that there may be some truth in the belief that marijuana causes laziness, in rats at least.
New findings reveal exercise increases levels of endocannabinoids in the body. The findings may explain some of the beneficial effects of exercise on the brain and body.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.
Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
